President Donald Trump said on Wednesday that there will be a tariff "wall" for pharmaceutical companies operating in the ...

The expiration of the TRIPS waiver is just one aspect of a broader set of challenges that the industry will need to address.

But international agreements are notoriously difficult to enforce, and pharma companies and patient advocates who were ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

President Trump announced a tariff “wall” for pharmaceutical companies in the US, potentially raising drug prices by nearly ...

Tariffs will likely cost Deerfield-based Baxter International $60 million to $70 million this year, the company’s chief ...

As Europe’s pharmaceutical giants warn of a potential €103 billion investment exodus, one Irish industry leader is pushing ...

NGES 4.0 leverages AI technology to enhance efficiency, refine management, and ensure compliance across various ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

The FDA does not plan a reorganization of the agency but will consolidate offices that handle travel and IT ...

A Cambridge-based pharmaceutical company is laying off close to a hundred employees. Ono Pharma USA, a subsidiary of the Japanese pharmaceutical company of the same name, filed with the state last ...

Baxter International, a prominent health care and pharmaceutical manufacturer, reports that President Trump's tariffs will ...